Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19146922rdf:typepubmed:Citationlld:pubmed
pubmed-article:19146922lifeskim:mentionsumls-concept:C0005682lld:lifeskim
pubmed-article:19146922lifeskim:mentionsumls-concept:C0037492lld:lifeskim
pubmed-article:19146922lifeskim:mentionsumls-concept:C0277785lld:lifeskim
pubmed-article:19146922lifeskim:mentionsumls-concept:C1419854lld:lifeskim
pubmed-article:19146922lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:19146922lifeskim:mentionsumls-concept:C1556066lld:lifeskim
pubmed-article:19146922lifeskim:mentionsumls-concept:C1619636lld:lifeskim
pubmed-article:19146922lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:19146922pubmed:issue1lld:pubmed
pubmed-article:19146922pubmed:dateCreated2009-2-11lld:pubmed
pubmed-article:19146922pubmed:abstractTextTetrodotoxin (TTX)-resistant sodium channels are found in small diameter primary sensory neurons and are thought to be important in the maintenance of inflammatory pain. Here we examined bladder urodynamics of Nav1.9 voltage-gated sodium channel knock out (KO) mice, and the contribution of Nav1.9 to the development of inflammation-based bladder dysfunction. Basal urodynamics were not different between wildtype (WT) mice and those lacking Nav1.9. Peripheral nerve recordings from pelvic afferents in Nav1.9 KO mice revealed a lack of sensitization to intravesicularly applied prostaglandin E2 (PGE2). Consistent with this, cyclophosphamide treatment in vivo, which is associated with an enhancement of PGE2 production, evoked a reduction in bladder capacity of WT, but not Nav1.9 KO mice. We conclude that the Nav1.9 sodium channel provides an important link between inflammatory processes and changes in urodynamic properties that occur during urinary bladder inflammation.lld:pubmed
pubmed-article:19146922pubmed:languageenglld:pubmed
pubmed-article:19146922pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19146922pubmed:citationSubsetIMlld:pubmed
pubmed-article:19146922pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19146922pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19146922pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19146922pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19146922pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19146922pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19146922pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19146922pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19146922pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19146922pubmed:statusMEDLINElld:pubmed
pubmed-article:19146922pubmed:monthMarlld:pubmed
pubmed-article:19146922pubmed:issn0304-3940lld:pubmed
pubmed-article:19146922pubmed:authorpubmed-author:MartinWilliam...lld:pubmed
pubmed-article:19146922pubmed:authorpubmed-author:ThorneloeKevi...lld:pubmed
pubmed-article:19146922pubmed:authorpubmed-author:RitterAmy MAMlld:pubmed
pubmed-article:19146922pubmed:issnTypePrintlld:pubmed
pubmed-article:19146922pubmed:day6lld:pubmed
pubmed-article:19146922pubmed:volume452lld:pubmed
pubmed-article:19146922pubmed:ownerNLMlld:pubmed
pubmed-article:19146922pubmed:authorsCompleteYlld:pubmed
pubmed-article:19146922pubmed:pagination28-32lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:meshHeadingpubmed-meshheading:19146922...lld:pubmed
pubmed-article:19146922pubmed:year2009lld:pubmed
pubmed-article:19146922pubmed:articleTitleThe voltage-gated sodium channel Nav1.9 is required for inflammation-based urinary bladder dysfunction.lld:pubmed
pubmed-article:19146922pubmed:affiliationDepartment of Immunology, Merck Research Labs, Rahway, NJ 06070, United States. a_m_ritter@hotmail.comlld:pubmed
pubmed-article:19146922pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19146922pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:19146922pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:24046entrezgene:pubmedpubmed-article:19146922lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19146922lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19146922lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19146922lld:pubmed